• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛磺胆酸直肠给药对健康人体胰高血糖素样肽-1 和肽 YY 分泌的影响。

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.

机构信息

Discipline of Medicine, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia.

出版信息

Diabetes Obes Metab. 2013 May;15(5):474-7. doi: 10.1111/dom.12043. Epub 2012 Dec 17.

DOI:10.1111/dom.12043
PMID:23181598
Abstract

Glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), secreted by enteroendocrine L-cells located most densely in the colon and rectum, are of fundamental importance in blood glucose and appetite regulation. In animal models, colonic administration of bile acids can stimulate GLP-1 and PYY by TGR5 receptor activation. We evaluated the effects of taurocholic acid (TCA), administered as an enema, on plasma GLP-1 and PYY, as well as gastrointestinal sensations in 10 healthy male subjects, and observed that rectal administration of TCA promptly stimulated secretion of both GLP-1 and PYY, and increased fullness, in a dose-dependent manner. These observations confirm that topical application of bile acids to the distal gut may have potential for the management of type 2 diabetes and obesity.

摘要

胰高血糖素样肽-1(GLP-1)和肽 YY(PYY)由分布在结肠和直肠的肠内分泌 L 细胞分泌,对于血糖和食欲调节具有重要意义。在动物模型中,胆汁酸通过 TGR5 受体激活可刺激 GLP-1 和 PYY 的分泌。我们评估了通过灌肠给予牛磺胆酸(TCA)对 10 名健康男性受试者血浆 GLP-1 和 PYY 以及胃肠道感觉的影响,结果发现 TCA 直肠给药可迅速刺激 GLP-1 和 PYY 的分泌,并以剂量依赖的方式增加饱腹感。这些观察结果证实,将胆汁酸局部应用于远端肠道可能有潜力用于治疗 2 型糖尿病和肥胖症。

相似文献

1
Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.牛磺胆酸直肠给药对健康人体胰高血糖素样肽-1 和肽 YY 分泌的影响。
Diabetes Obes Metab. 2013 May;15(5):474-7. doi: 10.1111/dom.12043. Epub 2012 Dec 17.
2
Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers.牛磺胆酸盐直肠给药可增加肥胖 2 型糖尿病志愿者的 L 细胞和胰岛素分泌,降低血糖和食物摄入。
Diabetologia. 2012 Sep;55(9):2343-7. doi: 10.1007/s00125-012-2593-2. Epub 2012 Jun 14.
3
Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans.牛磺胆酸对健康人体小肠葡萄糖输注后血糖、胰高血糖素样肽-1 和胰岛素反应的影响。
J Clin Endocrinol Metab. 2013 Apr;98(4):E718-22. doi: 10.1210/jc.2012-3961. Epub 2013 Feb 15.
4
Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha.静脉内和直肠内给予醋酸盐对胰高血糖素样肽-1、肽 YY、胃饥饿素、脂联素和肿瘤坏死因子-α的急性影响。
Br J Nutr. 2010 Feb;103(3):460-6. doi: 10.1017/S0007114509991863. Epub 2009 Oct 12.
5
The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY).肠表达的甜味受体在葡萄糖刺激胰高血糖素样肽-1(GLP-1)和肽 YY(PYY)分泌中的功能作用。
Clin Nutr. 2011 Aug;30(4):524-32. doi: 10.1016/j.clnu.2011.01.007. Epub 2011 Feb 15.
6
Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.肽YY、胰高血糖素样肽-1和神经降压素对离体血管灌注大鼠回肠腔内因素的反应。
Endocrinology. 1998 Sep;139(9):3780-6. doi: 10.1210/endo.139.9.6202.
7
Peptide YY is secreted after oral glucose administration in a gender-specific manner.口服葡萄糖后,肽YY以性别特异性方式分泌。
J Clin Endocrinol Metab. 2005 Dec;90(12):6665-71. doi: 10.1210/jc.2005-0409. Epub 2005 Sep 20.
8
Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?人体胃肠道的饱腹感信号——胰高血糖素样肽-1和酪酪肽的生理作用?
Physiol Behav. 2006 Nov 30;89(4):460-4. doi: 10.1016/j.physbeh.2006.05.048. Epub 2006 Jul 7.
9
Anorexigenic effects of miglitol in concert with the alterations of gut hormone secretion and gastric emptying in healthy subjects.米格列醇对健康受试者的摄食抑制作用及其对胃肠激素分泌和胃排空的影响。
Horm Metab Res. 2012 Apr;44(4):312-8. doi: 10.1055/s-0032-1304563. Epub 2012 Feb 20.
10
GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjects.GSK2374697是一种长效胰高血糖素样肽-1(GLP-1)受体激动剂,可降低健康受试者餐后循环中的内源性总GLP-1和肽YY水平。
Diabetes Obes Metab. 2015 Oct;17(10):1007-10. doi: 10.1111/dom.12533. Epub 2015 Aug 11.

引用本文的文献

1
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies.肠道微生物群与基于肠促胰岛素的疗法之间的双向相互作用。
Life (Basel). 2025 May 23;15(6):843. doi: 10.3390/life15060843.
2
Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration.二甲双胍可减缓2型糖尿病患者肠道对葡萄糖的吸收,且与其给药时间无关。
Diabetes Obes Metab. 2025 Sep;27(9):5370-5372. doi: 10.1111/dom.16570. Epub 2025 Jun 24.
3
GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation.
基于胰高血糖素样肽-1(GLP-1)的2型糖尿病治疗:从单一、双重和三重激动剂到内源性GLP-1生成及L细胞分化
Diabetol Metab Syndr. 2025 Feb 17;17(1):60. doi: 10.1186/s13098-025-01623-w.
4
Differential Impact of Medical Therapies for Acromegaly on Glucose Metabolism.肢端肥大症药物治疗对糖代谢的差异影响。
Int J Mol Sci. 2025 Jan 8;26(2):465. doi: 10.3390/ijms26020465.
5
Intermittent fasting and the liver: Focus on the Ramadan model.间歇性禁食与肝脏:聚焦斋月模式。
World J Hepatol. 2024 Aug 27;16(8):1070-1083. doi: 10.4254/wjh.v16.i8.1070.
6
Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption.胆汁酸吸收不良个体的肠肝循环、糖代谢及肠道微生物特征
Gastro Hep Adv. 2022 Mar 30;1(3):299-312. doi: 10.1016/j.gastha.2021.12.007. eCollection 2022.
7
Effects of Tryptophan Supplementation in Diets with Different Protein Levels on the Production Performance of Broilers.日粮中不同蛋白质水平下补充色氨酸对肉鸡生产性能的影响。
Animals (Basel). 2024 Jun 21;14(13):1838. doi: 10.3390/ani14131838.
8
The role of the gut microbiome in disorders of gut-brain interaction.肠道微生物群在肠-脑相互作用障碍中的作用。
FEBS J. 2025 Mar;292(6):1357-1377. doi: 10.1111/febs.17200. Epub 2024 Jun 23.
9
Sensing of luminal contents and downstream modulation of GI function.管腔内容物的感知及胃肠道功能的下游调节。
JGH Open. 2024 May 22;8(5):e13083. doi: 10.1002/jgh3.13083. eCollection 2024 May.
10
Coordinated ASBT and EGFR Mechanisms for Optimized Liraglutide Nanoformulation Absorption in the GI Tract.协调 ASBT 和 EGFR 机制以优化胃肠道中利拉鲁肽纳米制剂的吸收。
Int J Nanomedicine. 2024 Mar 23;19:2973-2992. doi: 10.2147/IJN.S442617. eCollection 2024.